Leadership & governance

Who stands behind Molliora.

A family entrusting its health coordination to an institution deserves to know who is responsible, how decisions are made and where the clinical boundary sits.

Portrait of Carl Martinsson

Carl Martinsson

Founder & Chief Executive

Carl leads institutional design, strategy, investor relationships and the Family Health Office model. It is personal: through four years in hospitals around the world with his child, whom he lost to cancer, he worked closely with doctors, specialists and researchers in several countries. Molliora is built on what he learned about finding the right care, quickly, and about what families need when it matters most.

LinkedIn →
Portrait of Helena Sundin

Helena Sundin

Co-Founder & Chief Operating Officer

Helena leads operations, member experience, delivery planning and the day-to-day operating foundations that keep responsibilities, providers and follow-up coherent around each family. She is a certified personal trainer and shapes Molliora’s work on movement, strength and everyday health.

LinkedIn →
Portrait of Patrick E Sewell, MD

Patrick E Sewell, MD

Co-Founder & Chief Medical Officer

Patrick is an interventional radiologist and oncologist with more than 30 years in medicine and a former Assistant Professor of Radiology and Surgery. At Molliora he leads clinical governance, safety and quality.

Clinical governance →
Portrait of Herry Gasser Han

Herry Gasser Han

Co-Founder & Chief Financial Officer

Herry leads financial control, capital planning, reporting and investor diligence, supporting disciplined growth and transparent stewardship of company resources.

LinkedIn →

Chief Medical Officer

Patrick E Sewell, MD

Patrick is an interventional radiologist and interventional oncologist with more than 30 years in medicine. He trained at Louisiana State University and the University of Mississippi Medical Center, where he served as Assistant Professor of Radiology and Surgery from 1996 to 2005.

He is one of the pioneers of image-guided tumour ablation. He performed the first MRI-guided renal tumour cryoablation, designed Boston Scientific’s line of radiofrequency ablation probes and treatment algorithms, and co-developed MRI-guided cryoablation equipment with Galil. He has held more than 30 invited visiting professorships in eight countries and published six books and more than 20 peer-reviewed papers indexed in PubMed, with over 100 papers and abstracts in total. He also founded Sapheneia, a medical imaging company with operations in the US and Sweden.

At Molliora he leads clinical governance, safety and quality.

He continues to publish on the biology of ageing, immune health and gene and cell therapy, and was granted a US patent in 2026. That is how Molliora judges new treatments: by the evidence, not the marketing.

“My role is not to replace your doctors. It is to make sure every one of them has everything they need to do their best work for you, and that your family understands every decision.”
Patrick E Sewell, MD · Co-Founder & Chief Medical Officer
Clinical governance and publications →

How we select specialists

Independently selected. Never pay-to-play.

Specialists are selected for relevance, demonstrated expertise and the needs of the family. Molliora does not sell access to members or publish private clinical relationships.

Clinical relevance

The right subspecialty, experience and institutional setting for the decision at hand.

Geographic reach

Relationships in the jurisdictions where member families live, travel and seek care.

Conflict review

Potential commercial and institutional conflicts are considered before a recommendation.

Our independence

We work for the family.

Molliora coordinates information, providers and agreed next steps. It does not diagnose, prescribe or replace treating physicians. Technology supports organisation and research; accountable people review outputs.

Governance

Visible responsibility.

Molliora GmbH is incorporated in Germany and operates under German corporate-governance standards and EU data-protection law (GDPR). Access to sensitive information follows an agreed role and purpose, material activity is traceable, and concerns are escalated to accountable leadership.

Request a confidential introduction

Every enquiry is reviewed personally.

Request a private introduction